New discoveries, everyday mysteries, and the science behind the headlines — in just under 15 minutes. It's science for everyone, using a lot of creativity and a little humor. Join hosts Emily Kwong and Regina Barber for science on a different wavelength.If you're hooked, try Short Wave Plus. Your subscription supports the show and unlocks a sponsor-free feed. Learn more at plus.npr.org/shortwave

New discoveries, everyday mysteries, and the science behind the headlines — in just under 15 minutes. It's science for everyone, using a lot of creativity and a little humor. Join hosts Emily Kwong and Regina Barber for science on a different wavelength. If you're hooked, try Short Wave Plus. Your subscription supports the show and unlocks a sponsor-free feed. Learn more at plus.npr.org/shortwave

Short Wave

Interim results are in from a large trial of an experimental COVID-19 vaccine. Drug maker Pfizer, working with German company BioNTech, says its vaccine appears to be working really well  — it was found to be more than 90 percent effective.  Today on Short Wave, host Maddie Sofia talks to NPR science correspondent Joe Palca about what that efficacy number means, details of the study and what more information about the vaccine researchers are awaiting.
Reach the show by emailing us at shortwave@npr.org.
Learn more about sponsor message choices: podcastchoices.com/adchoices
NPR Privacy Policy

Astronomi

Alam

Sains

Berita Harian

Ilmu Kehidupan

Berita 

https://chrt.fm/track/138C95/prfx.byspotify.com/e/play.podtrac.com/npr-510351/traffic.megaphone.fm/NPR7809196243.mp3?d=637&size=10209828&e=934164473&t=podcast&p=510351

The COVID-19 Vaccine Trial Results: What They Mean, What Comes Next